Edgewise Therapeutics Inc.

tag placeholder image

Edgewise reports Q2, continues to advance drug in trials

August 9, 2021 1:57:02 pm

tag placeholder image

Edgewise taps new chief medical officer

April 27, 2021 7:21:57 pm

tag placeholder image

Edgewise IPO, Inscripta round leads Colorado bioscience’s largest venture funding quarter on record

April 20, 2021 8:34:02 pm

tag placeholder image

Edgewise Therapeutics closes out surprise IPO with $202.4M raised

March 31, 2021 7:45:33 pm

tag placeholder image

Boulder’s Edgewise Therapeutics reveals $176M IPO plan after confidential filing

March 26, 2021 4:10:33 pm

tag placeholder image

Edgewise Therapeutics raises $95M to fund muscular-dystrophy drug trials

December 9, 2020 9:16:23 pm

« Previous Page